Semaglutide is normally effectively tolerated with comparable dropout premiums when put next with placebo, even though it could possibly be significantly less perfectly tolerated than dulaglutide (Trulicity).1,three The most common adverse outcomes are nausea, vomiting, and diarrhea and will be